Global “Research Antibodies Market” report offers an overview of the market size, share, trends, drivers, and barriers with respect to the Research Antibodies Industry. Latest report on the global Research Antibodies market is a compilation of key market insights and discusses key market dynamics such as drivers, restraints, and opportunities at length. It also provides a comprehensive overview of the market of different regions across North America, Europe, Asia Pacific, South America, Africa and Others.
The Research Antibodies
Market report discusses the primary industry growth drivers and challenges that
the vendors and the market as a whole face and provides an overview of the key
trends emerging in the market. It also talks about the market size of different
segments and their growth aspects along with key leading countries in Americas,
Asia-Pacific, Europe, the Middle East, and Africa regions.
Significant Features that
are under Offering and Key Highlights of the Reports:
• Detailed overview of Research
Antibodies Market
• Changing market dynamics
of the Research Antibodies industry
• In-depth market
segmentation by Type, Application etc
• Historical, current and
projected market size in terms of volume and value
• Competitive landscape of Research
Antibodies Market
• Strategies of key players
and product offerings
Get Free PDF Sample (Including Full TOC,
List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/research-antibodies-market/request-sample
Global Research Antibodies Market size is
expected to reach USD 4.30 billion by 2025. Antibodies are secreted immunoglobin
molecules mainly produced by plasma cells. They are a part of the body’s immune
system. The normal function of antibodies is to latch onto antigens and flag
them for destruction, thus helping to fight infection. The market is driven by
increasing R&D collaborations among various private & public
organizations to promote technical advancements in disease progression and
product development activities. The market size is expected to expand at a CAGR
of 6.1% in the upcoming period.
In research antibodies, some technologies are
used such as Immunohistochemistry, Western Blotting, Immunofluorescence,
Immunoprecipitation, Flow Cytometry, ELISA, and others. The “western blotting”
segment held largest market share in 2016 and is expected to hold the highest
market share in the upcoming period due to growing prevalence of diseases with
limited treatment options such as HIV. Western blotting is used in research
activities conducted by pharmaceutical & biotechnology companies as well as
academic institutes.
Product type such as primary and secondary
could be explored in research antibodies industry. Primary antibodies were the
most leading product type in 2016 due to greater specificity leading to
increased adoption in research activities. The segment is anticipated to grow
at the highest CAGR during the forecast period owing to the increasing adoption
of reagents containing primary research antibodies due to its related benefits
such as greater specificity, easy availability and suitability to various research
needs.
The factors that play an important role in
the growth of research antibodies market include increasing demand, growing
population, increasing urbanization & industrialization, increasing funding
for proteomics research & drug discovery, growing R&D activities &
expenditure in the life science industry, increasing demand for personalized
medicine & protein therapeutics, technological advancements and stringent
government rules & regulations. Moreover, increasing prevalence of breast
cancer and rising need for personalized medicine is stirring up the demand for
advanced techniques, which is creating ample growth of the market.
However, the quality concerns over research
antibodies, time & cost intensive antibody development processes and the
pricing pressures faced by market players are negatively impacting the growth
of research antibodies industry. The market is widely analyzed based on
different regional factors such as gross domestic product (GDP), demographics,
acceptance, inflation rate and others. The market is categorized based on
product, type, technology, source, application, end-use and geography.
The market is classified into type such as
monoclonal antibodies, polyclonal antibodies, and others. The “monoclonal
antibodies” accounted for the leading share in 2016 and is anticipated to grow
at a high CAGR in the next couple of years. Significantly rising number of
research activities in genomics that require technologically advanced genetic
platforms has led to increase the demand for monoclonal antibodies.
North America held largest market share in
2016 due to presence of many biopharmaceutical & biotechnology
manufacturers and academic institutes coupled with huge economic development.
Asia Pacific is expected to hold the highest market share in the forthcoming
years. The growing population, booming healthcare industry, increasing
innovation in antibody production and improving healthcare infrastructure
coupled with regulatory policies implemented by public healthcare organizations
to enhance safety are major factors driving the growth of the market in this
region.
Some of the companies for Research
Antibodies market are:
Abcam PLC, Agilent Technologies, Thermo
Fisher Scientific Inc., Merck Group, Becton, Dickinson and Company, Cell
Signaling Technology Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd,
GenScript, Danaher Corporation, PerkinElmer Inc., Genscript, BioLegend Inc. and
Lonza.
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment